The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CEVA | -26.53% | -47.68% | -12.15% | +283% |
| S&P | +12.28% | +84.74% | +13.06% | +634% |
CEVA, Inc. engages in the licensing of signal processing platforms and artificial intelligence processors to chip manufacturers. The firm offers Digital Signal Processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence. Its connectivity portfolio includes LTE and 5G mobile broadband platforms for handsets and base station RAN, NB-IoT for low bit rate cellular and Bluetooth and Wi-Fi technologies for wireless IoT. The company was founded on November 22, 1999 and is headquartered in Rockville, MD.
While megacaps dominate AI headlines, these nine smaller companies offer targeted exposure to edge computing, data infrastructure, and vertical AI applications at more reasonable valuations.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $28.38M | 4.3% |
| Gross Profit | $24.83M | 7.5% |
| Gross Margin | 87.46% | 2.6% |
| Market Cap | $630.73M | 10.3% |
| Market Cap / Employee | $1.47M | 0.0% |
| Employees | 428 | -4.9% |
| Net Income | -$2.51M | -91.4% |
| EBITDA | -$1.58M | 12.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $17.27M | 30.6% |
| Accounts Receivable | $49.70M | 28.7% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.54M | -3.2% |
| Short Term Debt | $1.24M | -52.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -3.69% | 1.4% |
| Return On Invested Capital | -3.23% | -0.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$6.29M | -41800.0% |
| Operating Free Cash Flow | -$5.86M | -1568.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.80 | 2.27 | 1.95 | 2.37 | 10.33% |
| Price to Sales | 6.97 | 5.58 | 4.94 | 5.88 | 4.77% |
| Price to Tangible Book Value | 3.63 | 2.93 | 2.51 | 3.06 | 9.95% |
| Price to Free Cash Flow TTM | 1445.25 | 576.87 | - | ||
| Enterprise Value to EBITDA | 547.68 | -128.70 | -108.58 | -306.93 | 31.44% |
| Free Cash Flow Yield | 0.1% | 0.2% | - | ||
| Return on Equity | -3.3% | -2.5% | -3.8% | -4.2% | -27.24% |
| Total Debt | $5.56M | $4.83M | $4.37M | $3.78M | -27.32% |
Berkshire Hathaway sticks to its main focus and is not lighting the world on fire, but it's still doing well.
Like many other industries, healthcare is turning to technology.
CEVA earnings call for the period ending June 30, 2022.
CEVA earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
